US Patent Number

7553496

Publication Date

6-30-2009

Abstract

The invention relates to methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization associated with neovascular disease. Administration of vascular endothelial growth factor (VEGF)-A into the eye when macrophage infiltration is reduced inhibits ocular angiogenesis.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

11/017,201

Filing Date

12/21/2004

Included in

Ophthalmology Commons

Share

COinS